<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Despite the recent success of <z:chebi fb="0" ids="38637">tyrosine kinase inhibitors</z:chebi> (TKIs) in the treatment of <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>), approximately 2-17% of patients develop clonal cytogenetic changes in the Philadelphia-negative (Ph(-)) cell population </plain></SENT>
<SENT sid="1" pm="."><plain>A fraction of these patients, in particular those displaying <z:mp ids='MP_0004027'>trisomy</z:mp> 8 or <z:mp ids='MP_0004026'>monosomy</z:mp> 7, are at risk of developing a <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) or <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Consequently, there is a need to characterize the clinical features of such cases and to increase our understanding of the pathogenetic mechanisms underlying the emergence of clonal cytogenetic changes in Ph(-) cells </plain></SENT>
<SENT sid="3" pm="."><plain>To date, most cases reported have received treatment with <z:chebi fb="0" ids="45783">imatinib</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Here we describe the case of a patient with <z:mp ids='MP_0005481'>CML</z:mp> who developed <z:mp ids='MP_0004026'>monosomy</z:mp> 7 in Ph(-) cells during <z:chebi fb="0" ids="49375">dasatinib</z:chebi> therapy </plain></SENT>
<SENT sid="5" pm="."><plain>At 20 months after <z:chebi fb="0" ids="49375">dasatinib</z:chebi> initiation, the patient developed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, which rapidly progressed into <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Genome-wide 500K SNP array analysis of the <z:mp ids='MP_0004026'>monosomy</z:mp> 7 clone revealed no acquired submicroscopic copy number changes </plain></SENT>
<SENT sid="7" pm="."><plain>Given the strong association between <z:mp ids='MP_0004026'>monosomy</z:mp> 7 and mutation of genes involved in the <z:mp ids='MP_0011356'>RAS</z:mp> pathway in juvenile myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo>, we also screened for pathogenetic variants in KRAS, NRAS, and PTPN11, but did not detect any changes </plain></SENT>
</text></document>